Skip to main content Skip to navigation
Make an Appointment Today 1-888-884-BEAR (2327) 1-888-884-BEAR (2327)
Find a Doctor Donate
Call Us Menu
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

FierceMedicalDevices Covered Sheikh Zayed Symposium Competition Winners AventaMed and Prospiria

October 27, 2015
Share:
Linked In Print Email
Fierce Medical Devices attended the third annual Shiekh Zayed Institute Pediatric Surgical Innovation Symposium and covered both medical device competition winners, AventaMed and Prospiria. Also interviewed, was last year's winner and 2015 competition judge, Justin Shaka of REBIScan.

Read the article, here. 

Latest Tweets

Follow

You Might Also Be Interested In:

2013 Hackathon: Student Innovators Design Mobile App

High school, college, and med school students worked together to design a mobile app to quell childhood obesity as part of the Student Innovator's 2013 Hackathon, a program within Children's National Health System's Sheikh Zayed Institute for Pediatric Surgical Innovation.

Robotic Surgery

Children’s National Hospital offers robotic surgery as a minimally invasive option for some pediatric urologic procedures, including pyeloplasty for obstruction and ureteral reimplantation for vesicoureteral reflux.

Autonomous surgical robot STAR named top ten finalist in NASA iTech challenge

Children’s National's proprietary robotic surgical technology Smart Tissue Autonomous Robot (STAR) has been named one of the top ten finalists in the 2017 NASA iTech call for ideas challenge.

Children’s National Health System to Launch Rheumatic Heart Disease Eradication Effort with $3.7 Million Grant from American Heart Association

Children’s National Health System has been awarded a $3.7 million grant from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing innovative strategies and economic incentives to improve the prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the United States.